Brief introduction of Zhejiang Huahai Pharmaceutical Co., Ltd.

The company has a registered capital of 299 million yuan, total assets of 654.38+07 billion yuan, an area of over 800,000 square meters and more than 2,800 employees. We have set up 65,438+065,438+0 branches in Linhai, Hangzhou, Shanghai and the United States respectively.

The company mainly deals in pharmaceutical preparations, bulk drugs and intermediates, and has formed a product pattern with obvious characteristics of cardiovascular drugs, antidepressants and antiviral drugs, refined but strong, serialization and large-scale development. Among them, ACE inhibitors, a cardiovascular drug, have the largest variety, the largest production and sales volume, and the world-leading technical level, enjoying the reputation of "Puli experts". The company has a sound management system, and all its products have passed the national GMP certification. It is one of the enterprises with the most international drug quality certification in China.

In June 2007, Nevirapine, the company's anti-AIDS drug, passed the US FDA certification with zero defects, becoming the first pharmaceutical company in China to obtain the certification, and obtained the pass for Huahai pharmaceutical products to enter the high-end markets in Europe and America, filling the gap in the export of China's pharmaceutical products to the United States, and setting up a proud monument in the history of China's pharmaceutical industry development.

On October 9th, 2006, the company was approved by the Leading Group for Enterprise Listing of Zhejiang Provincial People's Government in document [20065438+0] No.5. A joint-stock limited company established by the original shareholders of Zhejiang Huahai Pharmaceutical Group Co., Ltd. Chen Baohua, Zhou Minghua, thunis Science and Technology Innovation Investment Co., Ltd., Beijing Oriental Classic Business Consultant Co., Ltd., Zhejiang Yangmei International Petrochemical and Pharmaceutical Engineering Design Co., Ltd., Ningbo TEDA Import and Export Co., Ltd. and Shihui Lin * * * was registered in Zhejiang Administration for Industry and Commerce on February 28, 2006, with 5438+0. 65438 On October 28th, 2003, approved by China Securities Regulatory Commission, the company issued 35 million A shares to the public.